{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:41:43Z","timestamp":1793904103698,"version":"4.8.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmg.2026.105104","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:27:27Z","timestamp":1789169247000},"page":"105104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Neurofibromatosis 1 (NF1) gene testing reveals rising variant allele fraction as an early warning sign of juvenile myelomonocytic leukemia"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-1430","authenticated-orcid":false,"given":"Sirkku","family":"Peltonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Gr\u00f6nroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Paavola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Jahnukainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samppa","family":"Ryh\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Wallgren-Pettersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"P\u00f6yh\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilvi","family":"Riihil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Haanp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejmg.2026.105104_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104236","article-title":"Implications of mosaicism in variant interpretation: a case of a de novo homozygous NF1 variant","volume":"64","author":"Alghamdi","year":"2021","journal-title":"Eur. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ejmg.2026.105104_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0022-3476(78)80362-X","article-title":"Neurofibromatosis and childhood leukemia","volume":"92","author":"Bader","year":"1978","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2026.105104_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101818","article-title":"ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1","volume":"56","author":"Carton","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"11","key":"10.1016\/j.ejmg.2026.105104_bib4","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/ng.3420","article-title":"Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network","volume":"47","author":"Caye","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2026.105104_bib5","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood-2014-03-300319","article-title":"Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia","volume":"124","author":"Chang","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ejmg.2026.105104_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2008.162","article-title":"Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia","volume":"22","author":"Emanuel","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmg.2026.105104_bib7","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","article-title":"Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989","volume":"19","author":"Evans","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2026.105104_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2013.6434","article-title":"Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1","volume":"150","author":"Ferrari","year":"2014","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ejmg.2026.105104_bib9","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/sj.onc.1210361","article-title":"Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11","volume":"26","author":"Flotho","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ejmg.2026.105104_bib10","first-page":"1","article-title":"Juvenile myelomonocytic leukemia - a comprehensive review and recent advances in management","volume":"11","author":"Gupta","year":"2012","journal-title":"Am. J. Blood Res."},{"issue":"2","key":"10.1016\/j.ejmg.2026.105104_bib11","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1097\/MPH.0000000000002803","article-title":"Noonan Syndrome-related myeloproliferative disorder occurring in the neonatal period: case report and literature review","volume":"46","author":"Hoshino","year":"2024","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.ejmg.2026.105104_bib12","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation","volume":"23","author":"Legius","year":"2021","journal-title":"Genet. Med."},{"issue":"6","key":"10.1016\/j.ejmg.2026.105104_bib13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaad.2016.12.012","article-title":"The relationship between neurofibromatosis type 1, juvenile xanthogranuloma, and malignancy: a retrospective case-control study","volume":"76","author":"Liy-Wong","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.ejmg.2026.105104_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","article-title":"How I treat juvenile myelomonocytic leukemia","volume":"125","author":"Locatelli","year":"2015","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.ejmg.2026.105104_bib15","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.3390\/jcm10143084","article-title":"Current treatment of Juvenile Myelomonocytic leukemia","volume":"10","author":"Mayerhofer","year":"2021","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.ejmg.2026.105104_bib16","doi-asserted-by":"crossref","first-page":"e1380","DOI":"10.1111\/jdv.19321","article-title":"The association between juvenile xanthogranulomas in neurofibromatosis type 1 patients and the development of leukaemia: a systematic review","volume":"37","author":"Meyer","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.ejmg.2026.105104_bib17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1182\/blood.2025029916","article-title":"The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort","volume":"147","author":"Neven","year":"2026","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejmg.2026.105104_bib19","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospec-tive analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejmg.2026.105104_bib18","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2018-11-844688","article-title":"Juvenile myelomonocytic leukemia: who's the driver at the wheel?","volume":"133","author":"Niemeyer","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejmg.2026.105104_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/pde.13064","article-title":"Association between juvenile myelomonocytic leukemia, juvenile xanthogranulomas and neurofibromatosis type 1: case report and review of the literature","volume":"34","author":"Paulus","year":"2017","journal-title":"Pediatr. Dermatol."},{"issue":"11","key":"10.1016\/j.ejmg.2026.105104_bib21","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/ijc.32187","article-title":"Pediatric malignancies in neurofibromatosis type 1: a population-based cohort study","volume":"145","author":"Peltonen","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.ejmg.2026.105104_bib22","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1158\/1078-0432.CCR-17-0428","article-title":"Recommendations for surveillance for children with leukemia-predisposing conditions","volume":"23","author":"Porter","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ejmg.2026.105104_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1053\/j.semdp.2011.08.007","article-title":"Juvenile myelomonocytic leukemia","volume":"28","author":"Proytcheva","year":"2011","journal-title":"Semin. Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.ejmg.2026.105104_bib24","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjh.19190","article-title":"Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: genetic evidence of driver function and implications for diagnostic workup","volume":"2024","author":"Ramamoorthy","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.ejmg.2026.105104_bib25","doi-asserted-by":"crossref","first-page":"105.e1","DOI":"10.1016\/j.jtct.2023.10.002","article-title":"Allogeneic hematopoietic cell transplantation for juvenile myelomonocytic leukemia with a busulfan, fludarabine, and melphalan regimen: JPLSG JMML-11","volume":"30","author":"Sakashita","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ejmg.2026.105104_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2402271","article-title":"Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan","volume":"15","author":"Sasaki","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmg.2026.105104_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmg.2026.105104_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","article-title":"Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1","volume":"92","author":"Side","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejmg.2026.105104_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3324\/haematol.2009.010355","article-title":"Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1","volume":"95","author":"Steinemann","year":"2010","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.ejmg.2026.105104_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ejmg.2026.105104_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/jid.2014.465","article-title":"Incidence and mortality of neurofibromatosis: a total population study in Finland","volume":"135","author":"Uusitalo","year":"2015","journal-title":"J. Invest. Dermatol."},{"issue":"17","key":"10.1016\/j.ejmg.2026.105104_bib32","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmg.2026.105104_bib33","article-title":"A preterm newborn-onset juvenile myelomonocytic leukemia-like myeloproliferation with PTPN11 mutation","author":"Yamamoto","year":"2022","journal-title":"Pediatr. Blood Cancer"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721226000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721226000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:58:40Z","timestamp":1793901520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721226000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S1769721226000388"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2026.105104","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis 1 (NF1) gene testing reveals rising variant allele fraction as an early warning sign of juvenile myelomonocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2026.105104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105104"}}